A Phase 1 study of GSK5764227 in participants with advanced solid tumors
223054
Phase 1 other active
Quick answer
A Phase 1 study of GSK5764227 in participants with advanced solid tumors for Neoplasms is a Phase 1 program (other) at GlaxoSmithKline Biologicals S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline Biologicals S.A.
- Indication
- Neoplasms
- Phase
- Phase 1
- Modality
- other
- Status
- active